Adc Therapeutics Sa (ADCT)Eventide Asset Management, LLC exited its position 5.7M shares

5.7M

Prior-quarter shares · no longer reported

Holdings as of

Jun 30, 2026

Filed

Aug 14, 2026

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

1. Jun 30, 2026Company filing · Form 8-K · Executive changeChanged a top executive or board member“On June 30, 2026, the Board of Directors of ADC Therapeutics SA (the “Company”), with the advice of its independent compensation consultant, approved one-time retention awards (“Awards”) to certain of the Company’s employees, including its named executive officers as set forth below: Name Title Cash Incentive Award RSU Award Ameet Mallik Chief Executive Officer $1,795,500 675,000 Jose Carmona Chief Financial Officer…”
2. Aug 13, 2026Company filing · Form 8-K · Results, Reg FDReported its results, and shared information with investors

How to read SEC Form 13F-HR

Form 13F is the quarterly report in which investment managers that oversee $100 million or more list the US-listed stocks and some other securities they held on the last day of the quarter.

Full guide: What is an SEC Form 13F?

What else is on file for Adc Therapeutics Sa

For Adc Therapeutics Sa, OQRO holds 1 fund holdings report (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its ADCT page.

How this filing works

• SEC Form 13F

Other disclosures at Adc Therapeutics Sa

• SEC Form 13F-HRMay 15, 2026
• SEC Form 13F-HRMay 15, 2026
• SEC Form 4Apr 3, 2026
• SEC Form 4Apr 3, 2026
• SEC Form 4Apr 3, 2026
• SEC Form 4Apr 3, 2026

Everything OQRO holds on this company is on its ADCT page.